Evidence map›Paper›PMID 31347990›Full record

ArticleViral immunology2019

Seroprevalence of Cytomegalovirus Infection Among HIV-Infected and HIV-Uninfected Pregnant Women Attending Antenatal Clinic in Harare, Zimbabwe.

Doreen Mhandire, Kerina Duri, Mamadou Kaba, Kudakwashe Mhandire, Cuthbert Musarurwa, Emile Chimusa, Privilege Munjoma, Lovemore Mazengera, Babill Stray-Pedersen, Collet Dandara

Open access · hybridAbstract read
In one paragraph

Article in Viral immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Doreen MhandireDivision of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Kerina DuriDepartment of Immunology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Mamadou KabaInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Kudakwashe MhandireDepartment of Chemical Pathology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Cuthbert MusarurwaDepartment of Chemical Pathology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Emile ChimusaDivision of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Privilege MunjomaDepartment of Chemical Pathology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Lovemore MazengeraDepartment of Immunology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Babill Stray-PedersenInstitute of Clinical Medicine, University of Oslo and Women's Clinic, Rikshospitalet, University Hospital, Oslo, Norway.
Collet DandaraDivision of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
University of Zimbabwe · ZWUniversity of Cape Town · ZAOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the seroprevalence of cytomegalovirus (CMV) infection and risk factors associated with CMV acquisition among pregnant women in Zimbabwe. In a cross-sectional study, pregnant women were recruited in late gestation, seeking antenatal care at council clinics in three high-density suburbs in Harare, Zimbabwe. Anti-CMV IgM and IgG antibodies were quantified in serum using an enzyme-linked immunosorbent assay. Antibody avidity tests were used to distinguish active infection from viral reactivation in anti-CMV IgM-positive cases. Five hundred and twenty four women were recruited: 278 HIV infected and 246 HIV uninfected. Current or active CMV infection defined as IgM positive+low avidity was detected in 4.6% (24/524), 95% confidence interval (CI): 3-6.9 in all women, 5.8% (16/278) in the HIV infected and 3.3% (8/246), 95% CI: 1.4-6.3 in the HIV uninfected. IgG seroprevalence was 99.6% (522/524), 95% CI: 98.6-99.9 in all women. Notably, the difference in the prevalence of active CMV infection between the HIV-infected and HIV-uninfected women was not statistically significant (

Indexed as

AdultAntibodies, ViralCoinfectionCross-Sectional StudiesCytomegalovirusCytomegalovirus InfectionsFemaleHIV InfectionsHumansImmunoglobulin GImmunoglobulin MPregnancyPregnancy Complications, InfectiousPrenatal CareSeroepidemiologic StudiesYoung AdultAntibodies, ViralImmunoglobulin GImmunoglobulin Mactive infectioncytomegalovirusinfection reactivationreinfectionseroprevalencevertical transmission

Identifiers

PMID31347990
PMCPMC6751388
OpenAlexW2966204836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.